North Bay Business Journal

Novato’s Raptor has promising breast cancer inhibitor

NOVATO — A peptide acquired by Raptor Pharmaceutical Corp. as a possible delivery system for drug therapies has shown itself to be a direct inhibitor of the protein necessary for the growth of a particularly hard-to-treat form of breast cancer.